Last reviewed · How we verify
NCT06181097
Routine Use of Negative Pressure Wound Therapy THR TKR RCT
NA trial testing negative pressure wound therapy in Knee Arthropathy in 82 participants. Currently enrolling.
10 December 2025
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 82 |
| Start date | 11 December 2023 |
| Primary completion | 10 December 2025 |
| Estimated completion | 10 December 2026 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- negative pressure wound therapy
- standard dressing — full drug profile →
Conditions studied
- Knee Arthropathy — all drugs for Knee Arthropathy →
- Hip Arthropathy — all drugs for Hip Arthropathy →
- Negative Pressure Wound Therapy — all drugs for Negative Pressure Wound Therapy →
Sponsor
Chinese University of Hong Kong
Who can join
50 and older, any sex, with Knee Arthropathy or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Negative pressure wound therapy (NPWT) for post total joint arthroplasty incisions has demonstrated benefits in reducing wound complications. A prospective randomized trial will be conducted including 40 patients who will undergo total knee and total hip arthroplasty. The number of wound complications within 21 days will be recorded. As well, the aesthetic appearance and quality of scarring of the scar will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06181097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Arthropathy
Currently open trials in the same condition.
- NCT06720779 — Virtual Rehabilitation Platform for Patients With Knee Prothesis · NA · recruiting
- NCT06379321 — Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System · recruiting
- NCT06182059 — Persistent Post Surgical Pain After Total Knee Arthroplasty · NA · recruiting
- NCT06120023 — Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison · recruiting
- NCT06005623 — Motivational Feedback Following Total or Unicompartmental Knee Arthroplasty · NA · active not recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06181097 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 29 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06181097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing